362 POSTER A phase 2 trial of AP23573, an mTOR inhibitor, in patients (pts) with taxane-resistant androgen-independent prostate cancer (AIPC)

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements 2006-11, Vol.4 (12), p.112-112
Main Authors: Gross, M.E., Amato, R.J., Mushtaq, M., Wilding, G., Bubley, G.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(06)70367-6